Eli Lilly flags counterfeit Mounjaro seizure in Gurugram

The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.

FDA pushes forward on gene-editing therapies with new safety roadmap

Genome editing holds extraordinary promise for treating previously incurable genetic diseases

Galderma rolls out next-generation regenerating skin nectar

Experts endorse low-sodium salt substitutes to cut India’s hypertension burden

Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk

Salve Group launches Parasoft foot cream to address dry and cracked feet

This combination works to break down rough patches, improve moisture retention, and enhance overall skin texture

Piramal Pharma, Ajinomoto Bio-Pharma collaborate to accelerate ADC development

Collaboration integrates AJICAP™ technology with global manufacturing capabilities to streamline antibody-drug conjugate pipelines

India pushes policy action on adolescent nutrition as obesity concerns rise

ICMR-led consultation calls for stricter HFSS regulations, nutrition literacy, and healthier food environments

Rubicon forays into India's CNS segment with Rs 175.92 crore Arinna buy

Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%

Aurobindo’s TheraNym to invest up to $175 million in expanded biologics deal with MSD

TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility

Clean Cells, Naobios step up Asia expansion at BIO KOREA 2026 in Seoul

The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem